Growing research indicates that short protein treatments represent a innovative revolutionary area for tumor management. Unlike established drug therapy, these therapies can be created to specifically attack malignant tissue while limiting impact to non-cancerous tissue. This precision provides the possibility for improved efficacy and less toxici